{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:29Z","timestamp":1782902069292,"version":"3.54.5"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Efavirenz, a non-nucleoside reverse transcriptase inhibitor, is a preferred drug for the treatment of HIV-positive patients. However, one of its adverse effects is gynecomastia, which not only causes psychological distress to patients, affecting their daily lives and work, but also may undermine their treatment adherence. Although numerous studies have documented cases of gynecomastia in HIV-positive patients after antiretroviral therapy (ART), severe cases of gynecomastia are rarely reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient presentation<\/jats:title><jats:p>A 29-year-old male patient initiated a triple therapy regimen of efavirenz, lamivudine, and tenofovir disoproxil fumarate after being diagnosed with HIV. Two years later, he experienced progressive enlargement of the bilateral breasts but did not report the symptoms to his physician. After 6 years of ART, the patient developed grade III gynecomastia in both breasts, accompanied by significant psychological distress, prompting a visit to the breast surgery department. After excluding other potential drug adverse effects or underlying diseases, the patient\u2019s gynecomastia was attributed to efavirenz. Owing to severe enlargement of the breasts, the patient underwent bilateral mastectomy, successfully recovered and was discharged from the hospital. Postoperative follow-up revealed significant improvement in the patient\u2019s anxiety and depressive symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Gynecomastia represents a nonnegligible adverse effect of efavirenz that clinicians must recognize and manage promptly. Prior to initiating efavirenz therapy, it is imperative to thoroughly inform patients about potential adverse reactions, emphasizing the importance of seeking medical attention promptly should any side effects arise. Early detection and management of gynecomastia can mitigate its psychological impact and ensure continued adherence to ART.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1574364","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:32:19Z","timestamp":1758173539000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efavirenz-induced grade III gynecomastia in an HIV-positive male patient: a case report and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Lu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"ref1","article-title":"HIV data and statistics","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel","volume":"333","author":"Gandhi","year":"2024","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1186\/s12879-019-4332-5","article-title":"Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe","volume":"19","author":"Shawarira-Bote","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/CLEP.S470959","article-title":"Drug-induced gynecomastia: data mining and analysis of the FDA adverse event reporting system database","volume":"16","author":"Yang","year":"2024","journal-title":"Clin Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.6065\/apem.2346142.071","article-title":"Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment","volume":"29","author":"Metwalley","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1530\/EJE-16-0643","article-title":"Gynaecomastia in 786 adult men: clinical and biochemical findings","volume":"176","author":"Mieritz","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/17512433.2024.2429677","article-title":"A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting","volume":"17","author":"Deutscher","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12916-021-02080-8","article-title":"The effects of selected inhibitors on human fetal adrenal steroidogenesis differs under basal and ACTH-stimulated conditions","volume":"19","author":"Melau","year":"2021","journal-title":"BMC Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.etap.2019.02.007","article-title":"Environmental inhibitors of the expression of cytochrome P450 17A1 in mammals","volume":"69","author":"Peng","year":"2019","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000500522","article-title":"HIV drug Efavirenz inhibits CYP21A2 activity with possible clinical implications","volume":"91","author":"Malikova","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/0956462419895665","article-title":"Development of gynecomastia following initiation of bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"31","author":"Biagi","year":"2020","journal-title":"Int J STD AIDS"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.20945\/2359-3997000000010","article-title":"Assessing endocrine and immune parameters in human immunodeficiency virus-infected patients before and after the immune reconstitution inflammatory syndrome","volume":"62","author":"Rateni","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/bph.12480","article-title":"Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events","volume":"171","author":"Sv\u00e4rd","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1097\/CM9.0000000000003383","article-title":"Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection\/acquired immunodeficiency syndrome (2024 edition)","volume":"137","year":"2024","journal-title":"Chin Med J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"110129","DOI":"10.1016\/j.ijscr.2024.110129","article-title":"Experience in the use of circular incision bi-pedicled vertical flap based mastectomy for grade III gynecomastia: a case series","volume":"122","author":"Wijesinghe","year":"2024","journal-title":"Int J Surg Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bjps.2024.09.040","article-title":"Effective minimally invasive strategy for mixed-type gynecomastia using vacuum-assisted mastectomy and power-assisted liposuction","volume":"99","author":"Wang","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1574364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:32:20Z","timestamp":1758173540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1574364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":16,"alternative-id":["10.3389\/fmed.2025.1574364"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1574364","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1574364"}}